Abpro Holdings Inc

ABPWW

NASDAQ

Healthcare

Biotechnology

Woburn, MA, US6 employeesabpro.com

$0.01

+0.00(0.00%)

Mkt Cap $3M

$0.01

$0.06

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Research And Development Services (60%), Collaboration Revenue (32.5%), Royalty (7.5%).

8-K

Abpro Holdings Inc. disclosed under Item 3.01 on February 20, 2026, a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, occurring on February 18, 2026. This indicates potential non-compliance with exchange listing requirements.

$3M

Market Cap

$2M

Revenue

-$178M

Net Income

Employees6

Fundamentals

How The Business Makes Money

Revenue by Segment

Research And Development Services60%($183.0K)

Collaboration Revenue32.5%($99.0K)

Royalty7.5%($23.0K)

Activity

What Changed Recently

Delisting

Feb 19, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 18, 2026, Abpro Holdings, Inc. (the “Company”)

Delisting

Feb 10, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on January 28, 2026, Anthony D. Ei

Management Change

Feb 2, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January

Material Agreement

Jan 22, 2026

. Entry into a Material Definitive Agreement. On January 17, 2026, Abpro Holdings, Inc. (the “ Company ”) entered into a Loan Agreement with its Chief Executive

Regulation FD

Jan 5, 2026

of this Current Report on Form 8-K, including the exhibit, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act of 1934, as amended (the “

Peer Companies

Company	Price	Change	Market Cap	P/E
YDESYD Bio Limited Warrants	$7.01	-3.77%	$494M	-7.4
LEXXLexaria Bioscience Corp.	$1.04	+20.08%	$20M	-1.4
KZIAKazia Therapeutics Limite...	$7.27	+1.25%	$12M	-1.4
SNGXSoligenix, Inc.	$1.14	-0.87%	$11M	-0.5
QLGNQLGN	$3.21	+5.59%	$5M	—
XBIOXenetic Biosciences, Inc.	$2.98	+5.50%	$5M	-2.7
KALAKALA BIO, Inc.	$0.17	+4.11%	$4M	-0.0
TTNPTTNP	$2.34	-11.36%	$3M	—

Analyst View

Company Profile

CIK0001893219

ISINUS0008471114

CUSIP000847111

Phone617 225 0808

Address68 Cummings Park Drive, Woburn, MA, 01801, US

SEC EDGAR